IHS Chemical Week

EnviroTech :: R&D

Bayer HealthCare and Drug Development Company Covance Enter Strategic Partnership

5:40 AM MDT | May 30, 2012 | Natasha Alperowicz

Bayer HealthCare and Covance (Princeton, NJ) will establish a long-term strategic partnership in the area of clinical drug development, including R&D services related to phase II-IV clinical studies and central laboratory services. The new partnership marks the next step in cooperation both partners have developed over the past few years and represents the efforts to maximize its benefits across the Bayer HealthCare organization, Bayer says. Bayer’s goal is to leverage Covance’s broad range of experience and services across the R&D portfolio...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa